Skip to main
MCK

McKesson (MCK) Stock Forecast & Price Target

McKesson (MCK) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 40%
Buy 40%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

McKesson is a leading player in the US pharmaceutical wholesale industry, focused on expanding into higher-margin services and the biosimilars market while facing challenges in their RxTS segment and concerns related to opioid distribution. The company's strong financial position and investment in technology for efficiency make it a top choice, but changes in drug pricing and reimbursement models could pose risks. They are also spinning off their medical-surgical solutions segment and expanding into clinical research.

Bears say

McKesson is well-established in the competitive pharmaceutical wholesale industry, but their negative outlook is driven by potential risks such as decreasing employer coverage and rising competition from biosimilars. Additionally, while the company is prioritizing growth in certain segments, there are concerns about its sustainability efforts and plans to spin off a portion of its business. This, coupled with the company's heavy reliance on the U.S. market for revenue, warrants a negative outlook from a financial analyst's perspective.

McKesson (MCK) has been analyzed by 15 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 40% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of McKesson and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About McKesson (MCK) Forecast

Analysts have given McKesson (MCK) a Buy based on their latest research and market trends.

According to 15 analysts, McKesson (MCK) has a Buy consensus rating as of Sep 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $947.53, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $947.53, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

McKesson (MCK)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.